Vitetta Luis, Bambling Matthew, Strodl Esben
Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2005, Australia.
Faculty of Medicine and Health, The University of Queensland, Brisbane, QLD 4072, Australia.
Front Biosci (Landmark Ed). 2025 Mar 31;30(4):26837. doi: 10.31083/FBL26837.
The microbiota-gut-brain axis has been proposed as a potential modulator of mood disorders such as major depression. Complex bidirectional biochemical activities in this axis have been posited to participate in adverse mood disorders. Environmental and genetic factors have dominated recent discussions on depression. The prescription of antibiotics, antidepressants, adverse negative DNA methylation reactions and a dysbiotic gut microbiome have been cited as causal for the development and progression of depression. While research continues to investigate the microbiome-gut-brain axis, this review will explore the state of persistence of gut bacteria that underpins bacterial dormancy, possibly due to adverse environmental conditions and/or pharmaceutical prescriptions. Bacterial dormancy persistence in the intestinal microbial cohort could affect the role of bacterial epigenomes and DNA methylations. DNA methylations are highly motif driven exerting significant control on bacterial phenotypes that can disrupt bacterial metabolism and neurotransmitter formation in the gut, outcomes that can support adverse mood dispositions.
微生物群-肠-脑轴已被提出作为情绪障碍(如重度抑郁症)的潜在调节因子。该轴中复杂的双向生化活动被认为参与了不良情绪障碍。环境和遗传因素主导了近期关于抑郁症的讨论。抗生素的使用、抗抑郁药、不良的DNA甲基化反应以及肠道微生物群失调被认为是抑郁症发生和发展的原因。虽然研究仍在继续探究微生物群-肠-脑轴,但本综述将探讨肠道细菌的持续存在状态,这种状态可能是由于不利的环境条件和/或药物处方导致细菌休眠。肠道微生物群落中细菌休眠的持续存在可能会影响细菌表观基因组和DNA甲基化的作用。DNA甲基化高度受基序驱动,对细菌表型具有显著控制作用,可破坏肠道中的细菌代谢和神经递质形成,这些结果可能会导致不良情绪倾向。